IJMS | Free Full-Text | Cystic Fibrosis, CFTR, and Colorectal Cancer | HTML
How It Works | TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor)
From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations | Molecular Biology of the Cell
Mechanism of Action | TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor)
Allele-Specific Prevention of Nonsense-Mediated Decay in Cystic Fibrosis Using Homology-Independent Genome Editing: Molecular Therapy - Methods & Clinical Development
Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis - eBioMedicine
How It Works | TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor)
Cureus | A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
JCI Insight - Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
Downloadable Materials | TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor)
Elexacaftor/tezacaftor/ivacaftor - Wikipedia
Small molecule drugs in cystic fibrosis | ADC Education & Practice Edition
Frontiers | CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine | Pharmacology
Cells | Free Full-Text | Bicarbonate Transport in Cystic Fibrosis and Pancreatitis | HTML
How SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) Works
Elexacaftor-Tezacaftor-Ivacaftor: The First Triple-Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulating Therapy. - Abstract - Europe PMC
Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR - Journal of Cystic Fibrosis
Mechanism of Action | TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor)
Cystic fibrosis precision therapeutics: Emerging considerations - Joshi - 2019 - Pediatric Pulmonology - Wiley Online Library
Frontiers | CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine | Pharmacology
